Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Change in Account Payables (2021 - 2025)

Historic Change in Account Payables for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to -$168000.0.

  • Generation Bio's Change in Account Payables rose 2789.7% to -$168000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $418000.0, marking a year-over-year increase of 21058.2%. This contributed to the annual value of -$386000.0 for FY2024, which is 13551.06% down from last year.
  • As of Q3 2025, Generation Bio's Change in Account Payables stood at -$168000.0, which was up 2789.7% from $250000.0 recorded in Q2 2025.
  • Generation Bio's Change in Account Payables' 5-year high stood at $1.5 million during Q4 2021, with a 5-year trough of -$942000.0 in Q4 2022.
  • For the 5-year period, Generation Bio's Change in Account Payables averaged around $94526.3, with its median value being -$145000.0 (2021).
  • Data for Generation Bio's Change in Account Payables shows a peak YoY increase of 81304.35% (in 2022) and a maximum YoY decrease of 37172.41% (in 2022) over the last 5 years.
  • Over the past 5 years, Generation Bio's Change in Account Payables (Quarter) stood at $1.5 million in 2021, then tumbled by 162.67% to -$942000.0 in 2022, then skyrocketed by 68.26% to -$299000.0 in 2023, then fell by 2.68% to -$307000.0 in 2024, then surged by 45.28% to -$168000.0 in 2025.
  • Its Change in Account Payables stands at -$168000.0 for Q3 2025, versus $250000.0 for Q2 2025 and $643000.0 for Q1 2025.